Pulmonology

The Department of Pulmonology, inaugurated in June 2021, is a dedicated facility for the comprehensive management of respiratory conditions. Our unit comprises 32 beds, thoughtfully divided into 16 beds for male patients and 16 for female patients, with three beds allocated to our High Dependency Unit (HDU) on each side.

Administratively, we maintain two offices, one for the esteemed Associate Professor and the other for the diligent Assistant Professor. Additionally, we provide a well-appointed examination room for the on-duty physician, as well as a separate office and study area for our postgraduate trainees and medical officers.

Our department is fully equipped with state-of-the-art procedure rooms, including:

Bronchoscopy Suite: Our Bronchoscopy suite boasts cutting-edge technology and is staffed by a highly skilled medical team, ensuring the provision of minimally invasive diagnostic and therapeutic procedures for a wide spectrum of respiratory conditions.

Spirometry Lab: We house a dedicated room for pulmonary function testing, facilitating the diagnosis of various chest diseases.

Procedures Room: To further cater to the specific needs of pulmonary procedures, we offer a dedicated room within the unit.

Mission: Our overarching mission is to deliver the highest quality, accessible, and cost-effective patient care while actively contributing to the global endeavor to combat chest diseases, particularly preventable ones such as T.B, Pneumonia, COPD, Pneumoconiosis, and lung cancer through teaching and research.

Our department is equipped with a wide array of essential instruments and equipment, with Spirometry accessible for both outpatients and inpatients. We offer a comprehensive range of therapeutic and diagnostic services for patients with chest-related issues, including spirometry, pleural tap, pleural biopsy, tube thoracotomy, bronchoscopy, and pleurodesis. Additionally, CPAP and BiPAP machines are readily available to our patients. For outpatients, we have a dedicated office for the TB Control Program, staffed by a specialized team providing free drugs for TB patients. Furthermore, we have a programmatic management system for drug-resistant TB patients (PMDT Unit).

Trainings and Academic Activities: Our department has earned recognition from CPSP for both FCPS and MCPS courses. We are proud to have two consultants, one Associate Professor and one Assistant Professor of Pulmonology. The Associate Professor has successfully completed all necessary supervisor workshops and is an approved supervisor for FCPS/MCPS training. Currently, our department is fostering the growth of 16 postgraduate trainees in the field of pulmonology, with 8 FCPS TMOs and 8 MCPS TMOs. We have meticulously devised separate schedules and timetables for postgraduate and undergraduate student training and academic pursuits.

Research Activities: In terms of research, our consultant pulmonologists consistently publish a minimum of two articles each year in PNC recognized journals, reflecting our commitment to advancing the field.

Quality Index: Our department collaborates closely with the Quality Enhancement Cell at BKMC and the hospital's Quality Control Cell to maintain the highest standards of patient care. Rigorous clinical audits are an integral part of our routine, ensuring continuous improvements in patient care.

Future Plans: Our vision for the future includes:

1: Establishing a state-of-the-art skill lab for the training of undergraduate and postgraduate students.

2: Expanding our diagnostic and therapeutic bronchoscopy and thoracoscopy facilities within the unit.

3: Implementing a cutting-edge polysomnography diagnostic facility.

Dr. Sajjad Ali

Associate Professor

Dr. Nabi Rahman

Assistant Professor

O.P.D Days for Pulmonology/Chest
Section Name Monday Tuesday Wednesday Thursday Friday Saturday
Pulmonology O.P.D

We established Covid Triage system, covid isolation units, Covid HDU and Covid ICU in march 2020 under the care of pulmonology and since then we have admitted and treated about 3360 covid patients. About 2737 patients recovered and discharged and only 623 (18.52%) expired. We treated covid patients according to international and WHO COVID guidelines provided all possible available treatment modalities including plasma from covid recovered patients, monoclonal antibodies, (IL -6 inhibitors), antiviral drugs, CPAP, BIPAP and mechanical Ventilation. Most of the treatment was free of cost.